By leveraging physics-informed generative AI, mAIbe pioneers the creation of a groundbreaking platform designed to
designoptimizeproduce
anti-infective medicinal products
We are an innovative biotechnology startup which leverages advanced, Physics-informed Artificial Intelligence.
✦ Innovation
Benefits of AI
in drug discovery and development
Leveraging AI significantly reduces both the time and cost associated with traditional drug discovery.
AI accelerates the discovery and optimization process, potentially reducing development timelines by up to 50% compared to traditional methods.
AI-based approaches significantly reduce the need for costly and time-consuming laboratory experiments, cutting costs by as much as 60%.
AI-driven predictions improve the accuracy of evaluating antibody candidates for efficacy, stability, and safety, thereby increasing overall success rates from discovery through clinical trials.
-50%
TIME
-60%
COST
✦ Our Services
Powered by advanced AI
and Physics
Our team is developing a data- and model- driven platform specifically engineered for precise monoclonal antibody (mAb) design, using cutting-edge machine learning, physics-informed generative AI, and synthetic biology.
This innovative approach aims to reduce manufacturing costs, enhance accessibility to wider populations, and broaden the applications of monoclonal antibodies in emerging therapeutic needs.
Trusted by global brands. These are our Scientific Partners
Let’s connect.
mAIbe is driven by a passion for innovation, collaboration, and breakthrough in health sciences. Whether you’re looking to partner with us, explore investment opportunities, or join our team, we’d love to connect. Fill out the form below to start a conversation!
